Tumors actively prevent the formation of immune responses by cytotoxic T cells, which are essential in combating cancer. Researchers at the Technical University of Munich (TUM) and the Ludwig-Maximilians-Universität München (LMU) Hospital have now uncovered for the first time how this exactly happens.
Newly discovered mechanism helps tumor cells evade the immune system early on retrieved 24 April 2024 from https://medicalxpress.com/news/2024-04-newly-mechanism-tumor-cells-evade.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers stimulate gene that enhances CAR T-cell treatments for solid tumorsResearchers at Peter Mac have overcome a major barrier that could see a revolutionary immunotherapy treatment becoming successful on patients with solid cancer types.
Read more »
Triple-Negative Breast Cancer Tumors with Increased Immune Cells Have Lower Risk of RecurrenceA recent study has found that triple-negative breast cancer tumors with increased immune cells have a lower risk of recurrence after surgery. The study suggests that the presence of immune cells in the tumor microenvironment may play a role in preventing the recurrence of triple-negative breast cancer.
Read more »
Genetically engineering a treatment for incurable brain tumorsPurdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma.
Read more »
Study sheds light on the mechanisms underlying the development of malignant pediatric brain tumorsA study has revealed how aberrant epigenetic regulation contributes to the development of atypical teratoid/rhabdoid (AT/RT) tumors, which are aggressive brain tumors that mainly affect young children. There is an urgent need for more research in this area as current treatment options are ineffective against these highly malignant tumors.
Read more »
Epilepsy drug prevents brain tumors in mice with neurofibromatosis type 1A drug used to treat children with epilepsy prevents brain tumor formation and growth in two mouse models of neurofibromatosis type 1 (NF1), according to a study by researchers at Washington University School of Medicine in St. Louis.
Read more »
Softer tumors fuel more aggressive spread of triple-negative breast cancer, research showsResearchers have discovered how the mechanical properties of tumors can prime cancer cells to better survive their spread to other organs.
Read more »